<DOC>
	<DOC>NCT01509209</DOC>
	<brief_summary>The purpose of this study is to evaluate efficacy and safety of Cossac L tablet in the treatment of vasomotor rhinitis</brief_summary>
	<brief_title>Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis</brief_title>
	<detailed_description>randomized, double-blind, placebo-controlled, phase 3</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Vasomotor</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<criteria>Diagnosis of vasomotor rhinitis Significant concomitant medical condition Use corticosteroids or other allergy medications during the study Considered by investigator as not appropriate to participate in the clinical study with othe reason</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>vasomotor</keyword>
	<keyword>pseudoephedrine</keyword>
	<keyword>levocetirizine</keyword>
</DOC>